• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,913.50 -582.86
( -0.75%)
Global Indices
Nasdaq
49,530.46 -142.69
(-0.29%)
Dow Jones
7,252.74 22.73
(0.31%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,375.34 -3.48
(-0.03%)
Forex
USD-INR
94.96 0.17
(0.17%)
EUR-INR
111.11 0.25
(0.23%)
GBP-INR
128.48 0.55
(0.43%)
JPY-INR
0.60 0.01
(1.28%)

EQUITY - MARKET SCREENER

Aptus Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
544529
INE15XJ01010
29.1342566
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
277.83
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
Particulars(INCOME)Mar 2025
( Cr)
Mar 2024
( Cr)
Mar 2023
( Cr)
Sales Turnover 24.5617.8613.90
Excise Duty0.000.000.00
Net Sales24.5617.8613.90
Other Income 0.080.030.00
Stock Adjustments 3.631.130.90
Total Income28.2719.0214.80
EXPENDITURE :
Raw Materials 12.677.955.67
Power & Fuel Cost0.000.010.00
Employee Cost 3.472.311.57
Other Manufacturing Expenses 2.032.773.28
Selling & Administrative Expenses 4.944.233.41
Miscellaneous Expenses 0.230.170.25
Less : Pre-operative Expenses Capitalised 0.000.000.00
Total Expenditure23.3417.4314.19
Operating Profit4.931.570.62
Interest 0.470.240.14
Gross Profit4.461.330.48
Depreciation0.270.210.18
Profit Before Tax4.191.120.30
Tax1.110.340.12
Fringe Benefit tax0.000.000.00
Deferred Tax-0.02-0.02-0.02
Reported Net Profit3.100.800.19
Extraordinary Items 0.000.000.00
Adjusted Net Profit3.100.800.19
Adjustment below Net Profit -3.050.00-0.08
P & L Balance brought forward1.120.320.20
Statutory Appropriations0.000.000.00
Appropriations 0.000.000.00
P & L Balance carried down1.171.120.32
Dividend0.000.000.00
Preference Dividend0.000.000.00
Equity Dividend %0.000.000.00
Dividend Per Share(Rs)0.000.000.00
Earnings Per Share-Unit Curr6.2026.606.48
Earnings Per Share(Adj)-Unit Curr6.2026.606.48
Book Value-Unit Curr13.9358.8832.28
Book Value(Adj)-Unit Curr13.9358.8832.28